The objective of the research work described in this book was to develop molecular tools that can assist clinicians in taking more informed therapeutic decisions towards their HIV-1 infected patients. We demonstrated use of partial HIV-1 p24 gene sequence can function as a tool for viral subtyping. We report a HIV-1 viral load assay which is robust, reliable, economical and effective in resource limited settings like India. Through an extensive study spanning across 206 HIV-1 RT gene sequences, an effective and economical HIV-1 drug resistance genotyping method was developed and clinically validated. A primer extension-based process was explored for its ability to interrogate clinically important single nucleotide polymorphisms within the HIV-1 genome thus indicating its potential to be a cost effective, sensitive and specific HIV-1 mutation detection system. Finally we described a HCV genotyping assay, which has potential to influence therapeutic decisions in HIV-1/HCV co-infected patients. Our work will add value to the existing set of tools available for an inclusive management of HIV-1 that include HCV as a co-infection.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
The objective of the research work described in this book was to develop molecular tools that can assist clinicians in taking more informed therapeutic decisions towards their HIV-1 infected patients. We demonstrated use of partial HIV-1 p24 gene sequence can function as a tool for viral subtyping. We report a HIV-1 viral load assay which is robust, reliable, economical and effective in resource limited settings like India. Through an extensive study spanning across 206 HIV-1 RT gene sequences, an effective and economical HIV-1 drug resistance genotyping method was developed and clinically validated. A primer extension-based process was explored for its ability to interrogate clinically important single nucleotide polymorphisms within the HIV-1 genome thus indicating its potential to be a cost effective, sensitive and specific HIV-1 mutation detection system. Finally we described a HCV genotyping assay, which has potential to influence therapeutic decisions in HIV-1/HCV co-infected patients. Our work will add value to the existing set of tools available for an inclusive management of HIV-1 that include HCV as a co-infection.
Dr. Arpan Acharya, a molecular virologist received his PhD in Biotechnology (Molecular Biology) from Dr. D. Y. Patil Vidyapeeth, Pune, India. He completed his B.Tech in Pharmaceutical Technology and M.Tech in life Science and Biotechnology from Jadavpur University, Kolkata, India.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The objective of the research work described in this book was to develop molecular tools that can assist clinicians in taking more informed therapeutic decisions towards their HIV-1 infected patients. We demonstrated use of partial HIV-1 p24 gene sequence can function as a tool for viral subtyping. We report a HIV-1 viral load assay which is robust, reliable, economical and effective in resource limited settings like India. Through an extensive study spanning across 206 HIV-1 RT gene sequences, an effective and economical HIV-1 drug resistance genotyping method was developed and clinically validated. A primer extension-based process was explored for its ability to interrogate clinically important single nucleotide polymorphisms within the HIV-1 genome thus indicating its potential to be a cost effective, sensitive and specific HIV-1 mutation detection system. Finally we described a HCV genotyping assay, which has potential to influence therapeutic decisions in HIV-1/HCV co-infected patients. Our work will add value to the existing set of tools available for an inclusive management of HIV-1 that include HCV as a co-infection. 204 pp. Englisch. N° de réf. du vendeur 9783659888175
Quantité disponible : 2 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Acharya ArpanDr. Arpan Acharya, a molecular virologist received his PhD in Biotechnology (Molecular Biology) from Dr. D. Y. Patil Vidyapeeth, Pune, India. He completed his B.Tech in Pharmaceutical Technology and M.Tech in life Scienc. N° de réf. du vendeur 159147052
Quantité disponible : Plus de 20 disponibles
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26405915235
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 407271868
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18405915241
Quantité disponible : 4 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 204 pages. 8.66x5.91x0.46 inches. In Stock. N° de réf. du vendeur 3659888176
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The objective of the research work described in this book was to develop molecular tools that can assist clinicians in taking more informed therapeutic decisions towards their HIV-1 infected patients. We demonstrated use of partial HIV-1 p24 gene sequence can function as a tool for viral subtyping. We report a HIV-1 viral load assay which is robust, reliable, economical and effective in resource limited settings like India. Through an extensive study spanning across 206 HIV-1 RT gene sequences, an effective and economical HIV-1 drug resistance genotyping method was developed and clinically validated. A primer extension-based process was explored for its ability to interrogate clinically important single nucleotide polymorphisms within the HIV-1 genome thus indicating its potential to be a cost effective, sensitive and specific HIV-1 mutation detection system. Finally we described a HCV genotyping assay, which has potential to influence therapeutic decisions in HIV-1/HCV co-infected patients. Our work will add value to the existing set of tools available for an inclusive management of HIV-1 that include HCV as a co-infection.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 204 pp. Englisch. N° de réf. du vendeur 9783659888175
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. HIV-1 Genome Variations: Molecular Study and Economical Solutions | Arpan Acharya (u. a.) | Taschenbuch | 204 S. | Englisch | 2016 | LAP LAMBERT Academic Publishing | EAN 9783659888175 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 103708949
Quantité disponible : 5 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The objective of the research work described in this book was to develop molecular tools that can assist clinicians in taking more informed therapeutic decisions towards their HIV-1 infected patients. We demonstrated use of partial HIV-1 p24 gene sequence can function as a tool for viral subtyping. We report a HIV-1 viral load assay which is robust, reliable, economical and effective in resource limited settings like India. Through an extensive study spanning across 206 HIV-1 RT gene sequences, an effective and economical HIV-1 drug resistance genotyping method was developed and clinically validated. A primer extension-based process was explored for its ability to interrogate clinically important single nucleotide polymorphisms within the HIV-1 genome thus indicating its potential to be a cost effective, sensitive and specific HIV-1 mutation detection system. Finally we described a HCV genotyping assay, which has potential to influence therapeutic decisions in HIV-1/HCV co-infected patients. Our work will add value to the existing set of tools available for an inclusive management of HIV-1 that include HCV as a co-infection. N° de réf. du vendeur 9783659888175
Quantité disponible : 1 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
paperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA82936598881766
Quantité disponible : 1 disponible(s)